• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性标记免疫淋巴细胞在同基因肿瘤中的选择性定位。

Selective localization of radiolabeled immune lymphocytes into syngeneic tumors.

作者信息

Mulé J J, Jones F R, Hellström I, Hellström K E

出版信息

J Immunol. 1979 Aug;123(2):600-6.

PMID:458150
Abstract

Newly formed long-lived small lymphocytes (LLSL) generated during the immunization of mice to tumor specific transplantation antigens (TSTA) of syngeneic MCA-induced sarcomas were labeled. We then studied the localization of these labeled cells into tumor implants. "Crisis-cross" experiments were performed in which MCA sarcomas with individually distinct TSTA were studied in parallel. A selective localization of LLSL into tumors to which the lymphocytes were immune was found when small tumor pieces were implanted into immune mice whose LLSL had been labeled. Selective localization was also detected upon adoptive transfer of immune LLSL to tumor-bearing mice, but only when these mice had, before transfer, received a sublethal dose of whole body irradiation.

摘要

在将小鼠免疫于同基因甲基胆蒽诱导肉瘤的肿瘤特异性移植抗原(TSTA)过程中产生的新形成的长寿小淋巴细胞(LLSL)被标记。然后我们研究了这些标记细胞在肿瘤植入物中的定位。进行了“交叉”实验,其中并行研究了具有各自不同TSTA的甲基胆蒽肉瘤。当将小肿瘤块植入其LLSL已被标记的免疫小鼠体内时,发现LLSL选择性地定位于淋巴细胞免疫的肿瘤中。在将免疫的LLSL过继转移给荷瘤小鼠时也检测到了选择性定位,但前提是这些小鼠在转移前接受了亚致死剂量的全身照射。

相似文献

1
Selective localization of radiolabeled immune lymphocytes into syngeneic tumors.放射性标记免疫淋巴细胞在同基因肿瘤中的选择性定位。
J Immunol. 1979 Aug;123(2):600-6.
2
Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.原发性3-甲基胆蒽诱导的BALB/c肉瘤上的交叉反应性肿瘤相关移植抗原
Mol Biother. 1989;1(4):223-8.
3
Adoptive immunotherapy of newly induced murine sarcomas.新诱导的小鼠肉瘤的过继性免疫疗法。
Cancer Res. 1985 Apr;45(4):1657-62.
4
Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.甲种小鼠肉瘤的静脉内治疗性过继免疫疗法。组织学和免疫组织化学评估。
Lab Invest. 1985 Mar;52(3):304-13.
5
Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.新诱导肉瘤的过继性免疫治疗:效应细胞的免疫学特征
J Immunol. 1985 Oct;135(4):2895-903.
6
Cell surface phenotypes of radiolabeled immune long-lived lymphocytes that selectively localize in syngeneic tumours.选择性定位于同基因肿瘤中的放射性标记免疫长寿淋巴细胞的细胞表面表型。
Am J Pathol. 1982 May;107(2):142-9.
7
Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.同基因小鼠肉瘤已形成转移灶的过继性T细胞治疗中免疫相互作用的细胞基础。
J Immunol. 1988 Aug 1;141(3):1047-53.
8
In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells.在特定治疗效应细胞的生成过程中,利用活肿瘤细胞和白细胞介素-2进行体外致敏和扩增。
J Immunol. 1986 May 15;136(10):3891-8.
9
CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.用同基因肉瘤免疫的小鼠的CD4 + T细胞识别不同的、非共享的肿瘤抗原。
Cancer Res. 1994 Feb 15;54(4):1055-8.
10
Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.用可溶性肿瘤特异性移植抗原对致癌物诱导的小鼠肉瘤进行免疫治疗。
J Natl Cancer Inst. 1980 Nov;65(5):1001-4.

引用本文的文献

1
Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity.关于肿瘤免疫中 B 细胞的促肿瘤和抗肿瘤特性的新观点。
Front Immunol. 2022 Jul 28;13:881427. doi: 10.3389/fimmu.2022.881427. eCollection 2022.
2
Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response.黑色素瘤中肿瘤浸润淋巴细胞的组织病理学及宿主免疫反应的思考
Cancer Immunol Res. 2015 Aug;3(8):827-35. doi: 10.1158/2326-6066.CIR-15-0143.
3
Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.
短暂性淋巴清除后程序性死亡受体-1/程序性死亡受体配体-1 阻断治疗骨髓瘤。
J Immunol. 2013 Jun 1;190(11):5620-8. doi: 10.4049/jimmunol.1202005. Epub 2013 Apr 24.
4
Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells.低剂量全身辐射增强抗肿瘤免疫与选择性降低 T 调节细胞的比例和数量有关。
Cell Mol Immunol. 2010 Mar;7(2):157-62. doi: 10.1038/cmi.2009.117. Epub 2010 Feb 8.
5
Administration of cyclophosphamide changes the immune profile of tumor-bearing mice.环磷酰胺给药改变荷瘤小鼠的免疫特征。
J Immunother. 2010 Jan;33(1):53-9. doi: 10.1097/CJI.0b013e3181b56af4.
6
To ablate or not to ablate? HSCs in the T cell driver's seat.消融还是不消融?造血干细胞处于T细胞的主导地位。
J Clin Invest. 2007 Feb;117(2):306-10. doi: 10.1172/JCI30973.
7
Making room for T cells.为T细胞腾出空间。
J Clin Invest. 2002 Jul;110(2):157-9. doi: 10.1172/JCI16166.
8
Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.用全肿瘤裂解物脉冲处理的小鼠树突状细胞在体外和体内均介导强大的抗肿瘤免疫反应。
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9482-7. doi: 10.1073/pnas.95.16.9482.
9
Cell surface phenotypes of radiolabeled immune long-lived lymphocytes that selectively localize in syngeneic tumours.选择性定位于同基因肿瘤中的放射性标记免疫长寿淋巴细胞的细胞表面表型。
Am J Pathol. 1982 May;107(2):142-9.
10
Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.肿瘤白细胞浸润与宿主防御机制及预后的关系。
Cancer Metastasis Rev. 1984;3(1):53-74. doi: 10.1007/BF00047693.